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Hydrocephalus	is	a	common	and	potentially	devastating	birth	defect	affecting	the	CNS,	and	its	relationship	
with	G	protein–coupled	receptors	(GPCRs)	is	unknown.	We	have	expressed	2,	4,	or	6	copies	of	a	GPCR	—	the	
human	PAC1	receptor	with	a	130-kb	transgene	in	the	mouse	nervous	system	in	a	pattern	closely	resembling	
that	of	the	endogenous	gene.	Consistent	with	PAC1	actions,	PKA	and	PKC	activity	were	elevated	in	the	brains	
of	Tg	mice.	Remarkably,	Tg	mice	developed	dose-dependent	hydrocephalus-like	characteristics,	including	
enlarged	third	and	lateral	ventricles	and	reduced	cerebral	cortex,	corpus	callosum,	and	subcommissural	organ	
(SCO).	Neuronal	proliferation	and	apoptosis	were	implicated	in	hydrocephalus,	and	we	observed	significantly	
reduced	neuronal	proliferation	and	massively	increased	neuronal	apoptosis	in	the	developing	cortex	and	SCO	
of	Tg	embryos,	while	neurite	outgrowth	and	neuronal	migration	in	vitro	remain	uncompromised.	Ventricular	
ependymal	cilia	are	crucial	for	directing	cerebrospinal	fluid	flow,	and	ependyma	of	Tg	mice	exhibited	dis-
rupted	cilia	with	increased	phospho-CREB	immunoreactivity.	These	data	demonstrate	that	altered	neuronal	
proliferation/apoptosis	and	disrupted	ependymal	cilia	are	the	main	factors	contributing	to	hydrocephalus	
in	PAC1-overexpressing	mice.	This	is	the	first	report	to	our	knowledge	demonstrating	that	misregulation	of	
GPCRs	can	be	involved	in	hydrocephalus-related	neurodevelopmental	disorders.
Introduction
Hydrocephalus and neural tube defects (NTDs) are devastat-
ing birth defects affecting the CNS and are common worldwide. 
Hydrocephalus accounts for approximately 40% of these CNS 
abnormalities, and its causes remain obscure.
In mice, genetic alterations of signal transduction components 
are associated with CNS malformation. For example, Socs7 is a 
member of the suppressor of cytokine signaling family and reg-
ulates receptor tyrosine kinases. Around 50% of Socs7–/– mutant 
mice die within 15 postnatal weeks with hydrocephalus, thinned 
cerebral cortex, and disorganized subcommissural organ (SCO) 
(1, 2), all of which are commonly associated with human hydro-
cephaly (3). PKC is involved in neural induction, and mice lack-
ing PKC substrates myristoylated, alanine-rich C-kinase substrate 
(MARCKS), MARCKS-related protein, or p190 RhoGAP develop 
NTDs and hydrocephalus-related phenotypes, such as enlarged 
lateral ventricles (LVs), agenesis of the corpus callosum (cc), and 
lateral displacement of the forebrain (4–6). Specific PKC isoforms 
are required for the prevention of NTDs in curly tail mice (7). Inter-
estingly, increased PKC and diacylglycerol activities are also asso-
ciated with NTDs in a diabetic model (8). PKA is equally crucial 
for CNS development. PKA-null mutants are embryonic lethal, 
and mice with one-quarter of PKA activity show NTDs with a 
significantly enlarged lumen (9). PKA can phosphorylate and 
activate cAMP response element–binding protein (CREB). Signifi-
cantly, CREB–/– mice develop complications including dilated LVs 
and severely reduced cc and anterior commissures (10). Although 
many of the signal transduction components are implicated in 
CNS abnormalities, the identity of upstream components such as 
transmembrane receptors and ligands remains elusive.
We are interested in G protein–coupled receptors (GPCRs) for 
the neuropeptides pituitary adenylate cyclase–activating polypep-
tide (PACAP) and vasoactive intestinal peptide (VIP), for which 3 
receptors (VPAC1, VPAC2, and PAC1) are identified (11). VPAC1 
and VPAC2 receptors are equally sensitive to both peptides. Previ-
ously, we discovered that the VPAC2 receptor is essential for circa-
dian function (12, 13). However, the PACAP type I (PAC1) recep-
tor is selectively activated by PACAP, and its mRNA is expressed 
predominantly in the CNS (14). In mouse embryo, high levels of 
PAC1 mRNA are detected in the floor and roof plates of the neural 
tube (15), suggesting that PACAP plays important roles in the early 
development of the CNS.
Clinical evidence suggests that gain-of-function of chromosom-
al regions including genes in the PACAP signaling pathway leads 
to neurodevelopmental disorders. The PACAP gene (ADCYAP1) 
resides at 18p11. Fetuses with trisomy 18 develop microcephaly 
and spina bifida (16), and patients with tetrasomy 18p suffer from 
microcephaly, mental retardation, and congenital hydrocepha-
lus (17). The 18p11 region is also associated with an increased 
susceptibility to schizophrenia (18), and dilation of the LVs is a 
prominent anatomical feature in schizophrenia. The PAC1 gene 
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(ADCYAP1R1) is situated at 7p15. A patient with 7p15 duplica-
tion exhibits severe mental deficiency with communicating hydro-
cephalus (19). Indisputably, these chromosomal regions encode 
a large number of genes; however, this evidence collectively hints 
that elevated PACAP signaling through the PAC1 receptor may 
contribute to some of these neurologic manifestations.
To investigate the role of the PAC1 receptor in this regard, we 
have generated Tg mice overexpressing the human PAC1 receptor 
encoded by a 130-kb P1 bacterial artificial chromosome (PAC). 
The PAC was modified (20) to coexpress PAC1 and a lacZ reporter 
(with the use of a viral internal ribosomal entry site [IRES]) in the 
nervous system. Significantly, Tg mice developed hydrocephalus-
related phenotypes in a dose-dependent manner.
Results
Genomic organization of the human ADCYAP1R1 gene. Two positive 
clones (204D22 and 221D1) were identified from the RPCI-1 Human 
PAC Library (21) as containing the human ADCYAP1R1 gene (Fig-
ure 1B). The 130-kb clone 204D22 comprises the entire gene (~50 
kb) and approximately 70 kb of upstream sequence with sequence-
tagged site (STS) markers Wi-7721 and sWss1736. The 190-kb clone 
221D1 overlaps with 204D22 at the 3′ half of the ADCYAP1R1 gene 
and harbors D7S2679 and D7S2240 (Figure 1A).
We subcloned and sequenced the T7 ends of both clones. The 
end sequences and STS markers were used for DNA database 
searching. Three overlapping genomic segments (GenBank acces-
sion numbers AC005155, AC006466, and AC006398) were identi-
fied, enabling construction of a 356-kb contig flanking the human 
ADCYAP1R1 gene. 204D22 was found to start with Wi-7721 at nt 
65,850 of AC005155 and to terminate at nt 70,660 of AC006466; 
while 221D1 ended at nt 72,954 of AC006398. The marker 
Wi-7721 was derived from the 3′UTR of the gene encoding growth 
hormone–releasing hormone receptor (GHRHR), whose ligand 
belongs to the same neuropeptide superfamily including PACAP, 
suggesting that the ADCYAP1R1 and GHRHR genes may have 
evolved from a common ancestor.
The human PAC1 transgene and expression. We chose 204D22 to 
overexpress the human PAC1 receptor in mice, as bioinformatic 
analysis revealed that it encoded only the PAC1 receptor but no 
other functional genes (data not shown). To facilitate detection 
of transgene expression, we incorporated an IRES-lacZ reporter 
gene at the 3′UTR. The modified PAC DNA was introduced into 
fertilized eggs by pronuclear microinjection. Of 67 offspring, 9 
founders were identified to integrate the intact transgene, and 
8 Tg lines were established, with the exception of the highest 
expressing founder.
The transgene copy number was determined by semiquantitative 
PCR, with primers (PAC1For and PAC1Rev) from exons 7 and 
9 that are completely conserved between human and mouse. 
Ratios of the intensity of a 1.8-kb product (from the transgene) 
to that of a 1.4-kb band (from the endogenous gene, 2 copies) 
were quantified using NIH Image. Tg1, Tg2, and Tg3 lines were 
Figure 1
Genomic organization and expression of the human ADCYAP1R1 
transgene. (A) Mapping of the human ADCYAP1R1 gene encod-
ing the PAC1 receptor to 7p between STS markers sWss1736 
and D7S2679. (B) Overlapping of 221D1 with 204D22 at the 3′ 
half of the PAC1 receptor coding region. (C) Determination of 
transgene copy number by semiquantitative PCR with primers 
PAC1For and PAC1Rev. The ratios of the 1.8-kb band (human) 
to the 1.4-kb fragment (mouse) indicated that Tg1 (lane 1), Tg2 
(lane 2), and Tg3 (lane 3) contained 6, 4, and 2 copies of the 
transgene, respectively. (D) The expression of the human PAC1 
mRNA in E10.5 mouse embryos detected by RT-PCR with the 
primers PAC1For and PAC1Rev. RsaI restriction digestion of the 
PCR products resulted in 314-bp and 232-bp bands from human 
and mouse PAC1 mRNA, respectively. Human fetal cDNA (h) was 
included as a control. m, mouse. (E–G) X-gal staining of E10.5 
mouse embryos derived from lines Tg1 (E), Tg2 (F), and Tg3 (G), 
revealing transgene expression in the nervous system. (H–M) 
X-gal staining of coronal sections of adult brains, showing high 
levels of transgene expression in anterodorsal thalamic nucleus 
(AD; J), anterior hypothalamic nucleus (AHA; L), amygdala (Amg; 
M), anterior olfactory nucleus (Ao; H), anteroventral thalamic 
nucleus (AV; J), cingulate cortex (Cg; I), dentate gyrus (DG; K 
and M), frontal cortex (Fr; I), piriform cortex (Pir; J), paraventricu-
lar nucleus of the thalamus (Pv; J), reuniens thalamic nucleus 
(Re; J), and ventricular ependymal layer (vel; I, K and M).
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found to carry 6, 4, and 2 copies of the transgene, respectively, 
and characterized in detail (Figure 1C).
The transgene expression was analyzed by X-gal staining, which 
showed integration site–independent expression in the nervous 
system (Figure 1, E–G), closely resembling the endogenous expres-
sion pattern (15). Intense lacZ staining was observed in the roof 
and floor plates of the neural tube, the hindbrain, midbrain, and 
diencephalons, and the dorsal root ganglia. In adult brain, the lacZ 
expression patterns largely reproduced that of rodent PAC1 mRNA 
(14), with widespread expression in the CNS (Figure 1, H–M). The 
highest expression level was detected in the hippocampus, especial-
ly in granule cells of the dentate gyrus and pyramidal cells in the 
CA1–CA3 regions (Figure 1, K–M). Other prominent expression 
sites included cerebral cortex (especially the piriform, cingulate, 
and frontal cortices; Figure 1, I and J), the hypothalamus (espe-
cially the anterior hypothalamic area; Figure 1L), thalamic nuclei 
(including the anterodorsal, anteroventral, paraventricular, and 
reuniens nuclei; Figure 1J), the anterior olfactory nucleus (Figure 
1H), and the external granule cell layer of the cerebellum (data not 
shown). Strong b-gal activity was also observed in the ventricular 
ependymal layer (Figure 1, I, K, and M), the dorsal horn and central 
canal of spinal cord (Supplemental Figure 1; supplemental mate-
rial available online with this article; doi:10.1172/JCI27597DS1), 
the adrenal medulla (Supplemental Figure 1), and the inner nucle-
ar layer and ganglion cell layer of retina (data not shown).
To reveal the relative abundance of the transgene expression, we 
carried out RT-PCR with E10.5 RNA and primers PAC1For and 
PAC1Rev. The ratios of a 314-bp RsaI fragment (from human PAC1 
mRNA) to a 232-bp RsaI band (from mouse endogenous mRNA) 
confirmed transgene copy number–dependent expression of the 
human PAC1 receptor in all 3 Tg lines (Figure 1D).
Transgene dosage–dependent pre-weaning loss. The Tg founder (male) 
with the highest transgene copy number produced Tg embryos but 
no viable Tg offspring, suggesting that a high level of PAC1 recep-
tor expression could cause embryonic or early postnatal death. 
This was supported by other genotyping data in heterozygous 
(Het) × WT breeding. The offspring of Tg3 mice with 2 copies of 
the transgene exhibited a typical Mendelian ratio (41 Tg3/45 WT), 
while only 58% of Tg2 (4 copies, 110 Tg2/191 WT, ~6.1 mice/litter) 
and 51% of Tg1 (6 copies, 87 Tg1/172 WT, ~6.6 mice/litter) hetero-
zygotes survived to the weaning stage. Breeding records revealed 
13% postnatal loss within the first week in Tg1 and Tg2 lines. To 
determine possible embryonic lethality, 5 litters totaling 31 pups 
from Tg1 × WT mice (6.2 mice/litter) were dissected at E19.5 right 
before natural birth, and 15 of them were Tg (Figure 2F), showing 
no significant loss of Tg fetuses before birth.
At the weaning stage, Tg1 and Tg2 mice were notably smaller 
than WT littermates. To determine the timing of growth retarda-
tion, we analyzed P12, P7, E19.5, and E17.5 littermates (Figure 2). 
The Tg2 heterozygotes were significantly lighter than WT litter-
mates by P7 (P < 0.02) and P12 (P < 0.001). However, at E17.5 or 
E19.5, their differences were marginal. Therefore, growth retarda-
tion largely resulted from disadvantaged postnatal development.
Tg3 homozygotes also showed profound growth retardation 
(Figure 2B, right). Similar to Tg1 and Tg2 heterozygotes, a small 
proportion (5%) of Tg3 homozygotes developed a dome-shaped 
skull (Supplemental Figure 2), with excess cerebrospinal fluid 
(CSF), unfused frontal cortex (thin arrow, Figure 2D), and remark-
able thinning of occipital and parietal cortex (thick arrows, Figure 
2D). However, the majority of Tg mice did not display the typical 
dome-shaped skull, suggesting that only a small proportion of Tg 
mice developed overt hydrocephalus before fusion of the sutures.
Transgene dosage–dependent hydrocephalus-related phenotypes. To 
examine anatomic changes in the CNS of Tg mice, we processed 
histologically 8 brains of each Tg line and 8 brains of WT littermate 
adults. Morphological quantification of 14 brains (5 WT [Figure 
3, A and F] and 3 of each Tg line [Figure 3, B and G]) showed a 
clear transgene dosage–dependent dilation of the LVs (Figure 3, C 
and H) in Tg mice compared with WT littermates. In addition, the 
Figure 2
Growth retardation and hydrocephalus in PAC1-overexpressing 
mice. (A) A litter of P12 Tg3 heterozygote × heterozygote mice 
showed marked variation in body size. (B) The smallest littermate 
(right) weighed approximately a quarter of the normal weight (left) 
and displayed a mildly dome-shaped skull, typical of a progressive 
hydrocephalus phenotype. (C and D) Images of the same magni-
fication of brains were taken from a 5-week-old WT (C) and a Tg3 
homozygotic littermate (D), and the latter manifested severe hydro-
cephalus with unfused frontal cortex (thin arrow) and dramatically 
thinned occipital and parietal cortex (thick arrows). (E) The growth of 
Tg2 mice was significantly retarded by P7 and P12. (F) Tg1 but not 
Tg3 newborns were significantly smaller than their WT littermates at 
E19.5; however, the difference was marginal at E17.5. Neither Tg3 
nor Tg1 transgenics differed significantly from their WT littermates in 
brain weight (G) or ratios of brain to whole-body weight (H) at E17.5 
or E19.5. *P < 0.05; **P < 0.01.
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cerebral cortex and cc were also significantly thinned in brains of 
Tg mice (Figure 3, D, E, I, and J).
Ventricular ependymal cells are important for CSF circulation. 
High levels of transgene expression were observed in the ependyma 
of the LVs (Figure 1I), third ventricle (Figure 4, D and L), and aque-
duct (Figure 4H). The ependymal lining of the ventricles seemed 
intact in the Tg mice. However, the third ventricle was also expand-
ed in all Tg lines (Figure 4, B–D), and the aqueduct was enlarged 
and grossly deformed (Figure 4, F–H). The SCO is crucial for CSF 
flow through the aqueduct. Misexpression or deletion of transcrip-
tion factors such as Engrailed 1, RFX4, and Msx1 results in hydro-
cephalus associated with SCO malformation (22–24). The PAC1 
transgene was expressed strongly in the SCO (Figure 4L), and the 
sizes of SCO (Figure 4, J–L) and the numbers of SCO cells were sig-
nificantly reduced in Tg1 and Tg2 mice (Figure 4M; n = 3 each).
In patients, spina bifida is commonly associated with hydro-
cephalus. The PAC1 transgene was highly expressed in the devel-
oping neural tube (Figure 1, E–G) and adult spinal cord (Supple-
mental Figure 1). However, we did not observe failure of neural 
tube closure in Tg heterozygotes at any stage. Therefore, the 
hydrocephalus-related phenotypes are unlikely to be caused by 
defects in neural tube closure.
Congenital brain defects in the PAC1 Tg newborns. To investigate pos-
sible congenital abnormalities, we analyzed newborn (P1) brains 
from Het × WT offspring of Tg1 and Tg2 lines and from Het × Het 
offspring of Tg3 mice histologically and found a number 
of abnormalities. In WT littermates, the hippocampus 
appeared caudally to the septum, while hippocampus of 
Tg mice was remarkably rostralized and became visible 
before the merger of the bilateral septum (Figure 5B). 
In addition, it was displaced laterally from the midline 
(Figure 5, D, F, and H) and developmentally retarded (see 
Figure 5, G and H, for comparison). The cc was underde-
veloped (see Figure 5, C and D), and, consequently, the 
cerebral hemispheres of Tg mice were dislocated laterally, 
with a widened longitudinal fissure (arrows, Figure 5, B, 
D, F, and H). However, at E19.5 brains of Tg fetuses did 
not differ significantly from those of WT littermates in 
size, weight, or ratios of brain to whole body weight (Fig-
ure 2, F–H). The LVs of Tg mice were mildly enlarged (Fig-
ure 5, B and D) compared with those of WT littermates 
(Figure 5, A and C), suggesting that overt dilation of the 
ventricles in Tg adults largely developed after birth.
Reduced thickness of cerebral cortex and cc. The cc consists 
of nerve fibers projecting from cortical neurons to com-
municate between the 2 hemispheres. Thinned cc and cerebral cor-
tex were commonly present in all Tg adults (Figure 3, D, E, I, and 
J), indicating possible agenesis of the cc. In Tg newborns, they were 
also substantially reduced (Figure 5 and Figure 6E). In contrast, the 
cc was well formed and projected to the contralateral side in WT 
littermates (cc; Figure 5C and Figure 6D). Examination of serial 
Nissl-stained sections revealed that the cc was present only in a 
short medial region of Tg mouse brains, with a reduced thickness 
(Figure 6E), while in more rostral or caudal regions, it failed to cross 
the midline but formed large ipsilateral whorls of callosal axons 
known as Probst bundles (p; Figure 5, B and D). The development 
of anterior and posterior commissures was abnormal in some other 
hydrocephalic mice (10, 22, 24); however, they remained anatomi-
cally normal in our Tg mice (Figures 3B and Figure 4, J–L).
Two populations of midline glial cells, the glial wedge and 
the indusium griseum, are critical for axon guidance of cortical 
neurons and callosal formation (25). To investigate whether the 
thinned cc resulted from defects in axon guidance, we examined 
glial development in P1 mice immunohistochemically with anti–
glial fibrillary acidic protein (anti-GFAP), a marker for astrocytes. 
Slightly enhanced glial differentiation was observed in the glial 
wedge (Figure 6, D–G) and indusium griseum (arrows and insets, 
Figure 6, D and E) of Tg newborns. Additionally, the transgene 
was expressed abundantly in cortical layers V and VI (Figure 6C), 
and cerebral cortex of Tg mice was significantly reduced in layer V 
Figure 3
Morphometric evidence showing dose-dependent hydro-
cephalus in PAC1 Tg mice. (A, B, F, and G). Coronal sec-
tions of adult brains from WT (A and F) and Tg (B and G) 
mice were stained with cresyl violet. The sizes of ventricles 
(C and H), the thickness of the cerebral cortex (D and I) and 
of the cc (E and J), as well as the section area were quanti-
fied by AxioVision Rel. 4.5 (Zeiss) at comparable planes 
across the anterior commissure (ac; A and B) or optic chi-
asm (ox; F and G) from 5 WT and 3 Tg mice of each line. 
Note transgene dosage–dependent dilation of the LVs (C 
and H) and significant reduction of the cerebral cortex (D 
and I) and cc (E and J). *P < 0.05; **P < 0.01. Scale bars: 
1 mm in A, B, F, and G.
research article
1928	 The	Journal	of	Clinical	Investigation   http://www.jci.org   Volume 116   Number 7   July 2006
(Figure 6, A and B). These data suggest that reduced cortex and cc 
in Tg mice are largely due to lamination defects rather than com-
promised glial guidance of cortical axons.
Increased apoptosis and reduced proliferation in Tg embryos. The PAC1 
mRNA (15) and our transgene were expressed intensely in pro-
liferation zones of developing brain, indicating that PAC1 over-
expression may interfere with neurogenesis. Previously, PACAP 
antagonists were reported to increase proliferation of cortical pre-
cursors in E14.5 rat embryos in vitro (26), while intraventricular 
administration of PACAP into E15.5 rat brains inhibited mitosis 
of cortical precursors (27).
To explore the cellular mechanisms of hydrocephalus-like abnor-
malities in PAC1-overexpressing mice, we analyzed neuronal pro-
liferation and apoptosis by BrdU labeling and TUNEL assays. At 
mid-neurogenesis (E15.5), apoptosis was increased massively in 
the SCO (Figure 7, F and H), the ventricular ependyma (arrow-
head, Figure 7F), and the developing cortex (Figure 7, F and I). 
Within the cortex, apoptotic cells were intensively located in the 
cortical plate and marginal zone and to a much lesser degree in the 
proliferating zones (data not shown), indicating that the majority 
of apoptotic cells were postmitotic. Significantly, neuronal prolif-
eration was also reduced in proliferating zones of cortex in Tg mice 
(Figure 7, A–D and J). However, at the early (E12.5) or late (E17.5) 
stages of neurogenesis or in P1 brains, no significant difference in 
BrdU labeling was observed, nor was there a dramatic change in 
TUNEL labeling of P1 brains (data not shown).
Figure 4
Reduced SCO and dilated third ventricle (3V) and aqueduct in Tg mice. (A–D) Coronal sections across the optic chiasm showed an enlarged 
third ventricle (3V) in each of the 3 Tg lines (B–D) compared with their WT (A) littermates. (E–H) Comparison of coronal sections at the ventral 
tegmental decussation level displayed dilated aqueduct in all 3 Tg lines (F–H), with a morphology grossly different from that in the WT littermates 
(E). (I–L) Images of coronal sections at the posterior commissure (pc) level revealed reduced SCO in all 3 Tg lines (J–L) in comparison to the 
WT littermates (I). Sections in A–C, F, and I were stained with cresyl violet; sections in E, G, J, and K with H&E; and sections in D, H, and L with 
X-gal and neutral red. Note transgene expression in the ependymal cells (vel) of the third ventricle (D and L) and aqueduct (H) and in the SCO 
(arrow, L). (M) The SCO cell numbers at the pc level were significantly reduced in Tg2 and Tg1 mice. *P < 0.05. Aq, aqueduct. Scale bars: 100 
mm in A–D and I–L; 50 mm in E–H.
Figure 5
Congenital brain abnormalities in PAC1 Tg mice. Nissl staining of seri-
al coronal sections in a rostral-to-caudal direction from P1 WT (A, C, 
E, and G) and Tg (B, D, F, and H) mice. Tg mice manifested a number 
of abnormalities, including dilated LVs, thinned cortex (Ctx), uncrossed 
cc and formation of Probst bundles (p), widened longitudinal fissure 
between the 2 hemispheres (arrows), and rostralization together with 
underdevelopment of the hippocampus (Hi). CPu, caudate putamen; 
MD, mediodorsal thalamus; ME, median eminence; mt, mammillotha-
lamic tract; Sep, septum.
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Reduced BrdU labeling may result from increased apoptosis. 
Therefore, we quantified BrdU-positive and total cells in a 0.01-
mm2 area of E15.5 proliferating zones. Tg and WT embryos did 
not differ significantly in total cell numbers (WT, 316 ± 15.6 cells; 
Tg, 307 ± 11.7 cells; n = 5 each; P > 0.05; Figure 7J) or in cell den-
sity. However, the proportion of BrdU-labeled cells was reduced 
from 44% to 29% (n = 5 each; P < 0.01; Figure 7K), suggesting that 
PAC1 overexpression caused a substantial proportion of neural 
progenitors to exit the mitotic phase, in harmony with previous 
reports (26, 27). Therefore, both reduced neuronal proliferation 
and increased apoptosis are associated with the hydrocephalus-
related defects in the Tg mice.
PAC1 overexpression affects neurogenesis rather than oligodendrocyte 
production. PACAP was shown to stimulate proliferation of oligo-
dendrocytes in neonatal rats (28). To determine the effect of PAC1 
overexpression on oligodendrocyte production in vivo, we immu-
nolabeled E15.5 dorsal telencephalon with BrdU and PDGFRa 
(a marker for early oligodendrocyte progenitors [OLPs]). Weak 
staining of PDGFRa was found in both the ventricular and sub-
ventricular zones (Figure 8, C and D), but there was no dramatic 
difference in the cortex between Tg and WT embryos. Because of 
multiple origins of oligodendrocytes at different developmental 
stages and possible transdifferentiation of radial glia into oligo-
dendrocytes after birth, we have examined P12 cortex (data not 
shown) and striatum (harboring abundant oligodendrocytes) with 
Sox10, a marker for later OLPs and mature oligodendrocytes, and 
observed no apparent difference between the 
WT and Tg mice (Figure 8, E and F). BrdU-
positive cells were mainly located in the sub-
ventricular zone, and reduced proliferation 
in the cortex of Tg embryos correlated with 
expression of GLAST, a marker for radial 
glia (Figure 8, A and B). Collectively, these 
data indicate that reduced proliferation 
in the cortex of Tg embryos mainly affects 
ongoing neurogenesis rather than oligoden-
drocyte production.
Effects of PACAP on neurite outgrowth and 
neuronal migration in vitro. Thinner cerebral 
cortex and cc in the Tg mice may result 
from defects in neurite outgrowth and/or 
neuronal migration. To examine this pos-
sibility, we cultured primary neurons from 
E15.5 cortices of Tg and WT littermates in 
the absence (Figure 9, A and C) or presence 
of 10–7 M PACAP (Figure 9, B and D) and 
measured neuronal migration in an 8-hour 
period (Figure 9E). Neurons from Tg embry-
os did not display defects in PACAP-induced 
neurite outgrowth (Figure 9D) compared 
with those from WT embryos (Figure 9B). 
In addition, the neurons from Tg migrated 
faster than those from WT embryos in the 
presence of PACAP (Figure 9E and Supple-
mental Video), suggesting that neurons 
of Tg embryos are unlikely to have major 
defects in neurite outgrowth or migration.
Disrupted cilia in ventricular ependyma of Tg 
mice. The PAC1 receptor is highly expressed 
in the ventricular ependymal cells (Figure 1, 
I, K, and M), and coordinated beating of ependymal cilia is required 
to direct CSF flow. Cilia are highly structured, with microtubule-
based large complexes known as intraflagellar transport (IFT) par-
ticles required for bidirectional movement of proteins between the 
base and the tip of cilia (29). An insertional mutation in a gene 
(Tg737) encoding Polaris, a component of the IFT particles, result-
ed in severe developmental defects, including hydrocephalus with 
disrupted cilia formation (30).
To examine whether PAC1 Tg mice have defects in the ventricu-
lar ependyma, we immunolabeled 5-week brain sections with Abs 
against acetylated a-tubulin and Polaris, key components of the 
IFT. WT ependymal cells were polarized, with oriented bundles of 
motile cilia of uniform length protruding into the LV lumen (red, 
Figure 10, A and B). In contrast, Tg mice had fewer cilia, and many 
of them were shorter, disorganized, and disorientated, as illus-
trated by anti–acetylated a-tubulin staining (red, Figure 10, C–E). 
However, ependymal expression/localization of Polaris (Figure 10, 
A–E) and choroidal cilia (Figure 10, H and I) appeared normal in Tg 
mice. These data showed that hydrocephalus-like defects in PAC1 
Tg mice are associated with severely disrupted ependymal cilia.
Elevated PKA/PKC signaling in brains of Tg mice. The signaling 
pathways involved in cilia formation are unknown. PAC1 receptor 
activation can trigger multiple signaling pathways, including PKA 
and PKC (14, 31). MARCKS is one of the first substrates char-
acterized for PKC. Interestingly, MARCKS–/– mice exhibit dilated 
ventricles with complete agenesis of the cc and reduced cerebral 
Figure 6
Tg mice are defective in cortical lamination but less likely defective in axonal guidance. (A 
and B) Nissl staining of coronal brain sections of WT (inset, A) and Tg (inset, B) littermates 
revealed dilated ventricles. Magnified images of the boxed regions shown in the insets of A 
and B illustrate thinned cerebral cortex and cc. Note that layer V was significantly reduced, 
with fewer large neurons (pyramidal). (C) X-gal staining showed transgene expression largely 
at layers V and VI. (D and E) Glial fibrillary acidic protein (GFAP) immunostaining of brains 
of P1 WT mice (D) and Tg littermates (E) demonstrating a similar staining pattern at the glial 
wedge (black boxes) and the indusium griseum (arrows), magnified in the insets. Note that the 
thickness of cc (delineated by vertical lines) was also reduced in Tg newborns. F and G show 
magnification of the glial wedges delineated by the black boxes in D and E, revealing slightly 
more glial staining in Tg mice (G). Scale bars: 200 mm in A–E; 50 mm in F and G and insets of 
D and E; 1 mm in insets of A–C.
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cortex (5). CREB is a well-characterized substrate for PKA, and 
CREB–/– mice show enlarged LVs with severely reduced cc and 
anterior commissures (10).
To determine changes of PKA/PKC activity in Tg mice, we immu-
nolabeled brain sections with Ab against phosphorylated CREB 
(phospho-CREB). In agreement with elevated PACAP signaling, 
phospho-CREB was significantly increased in ependymal nuclei 
of Tg mice (Figure 10, F and G). To quantify PKA/PKC activity, 
we analyzed levels of phospho-CREB and phospho-MARCKS by 
immunoblotting. As anticipated, PAC1 overexpression did not 
alter the total level of MARCKS expression (Figure 11B). However, 
phospho-MARCKS was increased significantly in brains of Tg mice 
and correlated with transgene dosage (Figure 11B). Interestingly, 
both total CREB and phospho-CREB were increased in brains of 
Tg mice (Figure 11A). Our results, together with previously pub-
lished data from CREB–/– and MARCKS–/– mutants, suggest that 
both gain- and loss-of-function in PKA/PKC signaling may lead to 
hydrocephalus-related manifestations.
Discussion
We have developed Tg mice overexpressing the human PAC1 
receptor. Tg mice showed marked reductions in the cerebral cor-
tex, cc, and SCO together with decreased neuronal proliferation 
and accelerated apoptosis. Consistent with receptor signaling, 
both PKA and PKC activity were increased in brains of Tg mice. 
Ventricular ependyma of Tg mice displayed 
elevated phospho-CREB immunoreactivity 
and disorganized cilia. Most importantly, Tg 
mice developed transgene dosage–dependent 
hydrocephalus with dilated third and LVs. 
These results constitute the first clear evi-
dence to our knowledge that GPCRs can be 
involved in hydrocephalus-like neurodevelop-
mental disorders.
Hydrocephalus and ependymal cilia. CSF is 
mainly produced by choroid plexus, and ven-
tricular ependymal cilia are vital for direct-
ing CSF flow. Crucially, abnormal cilia are 
found in patients with primary ciliary dys-
kinesia, a condition known to be associated 
with congenital heart disease and/or hydro-
cephalus (32). Within cilia, bidirectional 
movement of proteins is mediated through 
the microtubule-based IFT particles (29). In 
mice, mutations in key components (Polaris, 
Spag6, Hydin, or Mdnah) of IFT all result in 
hydrocephalus with impaired ependymal cilia 
function (30, 33–35). The PAC1 transgene is 
highly expressed throughout the ventricular 
ependyma. One possibility, therefore, is that 
PAC1 overexpression affects ependymal cilia 
via cytoskeleton-associated molecules. Indeed, 
ependymal cilia of Tg mice were fewer in 
number, shorter, and disorientated compared 
with WT. On the other hand, we detected no 
significant change of cilia in choroid plexus, 
consistent with an extremely low level of the 
transgene expression. These data indicate 
that disrupted ependymal cilia at least par-
tially contribute to progressive hydrocephalus 
in PAC1 Tg mice. Our preliminary observation suggests that CSF 
flow is affected in the Tg mice (data not shown).
Hydrocephalus and neuronal proliferation/apoptosis. Apoptosis 
was implicated in the development of hydrocephalus of Msx1 
mutants (24). However, hyperproliferation of neural progenitor 
cells was also associated with severe hydrocephaly in Lgl1–/– mice 
(36). We demonstrated remarkably reduced proliferation in the 
developing cortex, SCO, and ventricular ependyma of E15.5 Tg 
embryos, consistent with the previous observation that intra-
ventricular delivery of PACAP transiently inhibited mitosis in 
E15.5 rat brains (27). We also showed for the first time that PAC1 
overexpression significantly increased apoptosis, which was not 
apparent following intraventricular delivery of PACAP (27), and 
this might be due to rapid degradation of injected PACAP in 
vivo (37) or because prolonged elevation of PACAP signaling is 
required to trigger apoptosis.
Thinned cortex and cc can arise from aborted neurogenesis if 
newborn neurons have defects in neurite outgrowth or fail to 
extend their axons to the targeted destination. Our data show 
that neurite outgrowth or neuronal migration is not compro-
mised in Tg mice. Astrocytes at the glial wedge and the indusium 
griseum are critical for guiding axons to cross the midline (25). 
However, they are well developed in Tg newborns. On the other 
hand, we observed a dramatic reduction in cortical layer V, where 
a large proportion of callosal neurons reside. Therefore, the 
Figure 7
Decreased proliferation and increased apoptosis in E15.5 Tg embryos. (A–D) BrdU labeling 
of transverse sections of E15.5 Tg embryos and WT littermates. C and D are higher-power 
views of the boxed areas in A and B, respectively. Note the substantial reduction in BrdU 
incorporation in Tg embryos. (E and F) TUNEL assay of coronal sections of E15.5 WT (E) 
and Tg (F) embryos, demonstrating remarkable increases in apoptosis in the developing 
SCO (boxed areas, arrows), cortex (cortical plate and marginal zone in particular), and ven-
tricular ependymal cells (arrowheads) in Tg embryos. (G and H) Higher magnification of the 
SCO in E and F. TUNEL-labeled cells (I) in E15.5 cortex were quantified from 0.038 mm2 of 
3 sections of each embryo (WT, n = 4; Tg, n = 4). The number of BrdU-positive cells (J) or 
the total number of cells (J) and their ratios (K) within 0.01 mm2 of the proliferating zones of 
E15.5 cortex were quantified from 5 WT and 5 Tg embryos, showing significantly reduced 
neuronal proliferation. **P < 0.01. CsL, corpus striatum laterale; CsM, corpus striatum medi-
ale. Scale bars: 400 mm in A, B, E, and F; 100 mm in C, D, G, and H.
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thinned cc or failure of cc to cross the midline in Tg newborns is 
likely to result from defects in cortical lamination rather than in 
astrocyte differentiation.
A reduced number of oligodendrocytes may also cause thin-
ning of the cerebral cortex and/or cc. Recent studies revealed 3 
waves of OLP production in the developing forebrain, and a nor-
mal brain can be developed with a normal complement of oligo-
dendrocytes and myelin, even if any of the 3 OLP populations is 
destroyed (38). In line with this discovery, there were no appar-
ent changes in PDGFRa expression at E15.5 in the cortex of Tg 
embryos; nor was there an overt alteration of Sox10 expression 
in P12 mice. Additionally, the normal appearance of anterior and 
posterior commissures in Tg adults also excludes the possibility 
of abnormal oligodendrocyte production. Therefore, defects in 
cerebral cortex and cc of Tg mice are unlikely due to defects in 
oligodendrocyte production.
Hydrocephalus and posttranslational modifications. Socs7 regulates 
receptor tyrosine kinases, and deficiency of Socs7 causes hydro-
cephalus (1, 2). Hydrocephalus-related phenotypes are observed in 
mutants lacking PKC substrates (4–6) or PKA (9). However, elevated 
cAMP production also causes hydrocephalus in Tg737 mice (30). We 
have shown that PKA/PKC activity is increased in brains of Tg mice. 
Crucially, phospho-CREB is upregulated in ventricular ependymal 
cells, and cilia are disorganized in Tg mice. These data suggest that 
appropriate levels of PKA/PKC signaling are essential for normal 
ventricular function and that disruption of PKA/PKC signaling in 
ependymal cells may underpin a hydrocephalic phenotype.
PAC1 Tg and PAC1–/– mice. Gene dosage is crucial for normal 
brain development and physiological function. Often overdose 
and underdose cause similar abnormalities, and this is true for 
the PAC1 receptor. The PAC1-overexpressing and PAC1–/– mice 
displayed strikingly similar phenotypes. First, pre-weaning loss is 
common in PAC1–/– (39), PACAP–/– (40), and our Tg mice. Second, 
both PAC1–/– (39) and PAC1 Tg (data not shown) neonates rapidly 
develop pulmonary hypertension–related complications. Third, 
PAC1–/– mutants show altered response to photic stimulation (41), 
and circadian function is also modulated in PAC1 Tg mice (data 
not shown). Fourth, PAC1-overexpressing and PAC1–/– (data not 
shown) newborns displayed similar brain abnormalities.
It is increasingly recognized that many human diseases do 
not result from deletions or mutations in coding sequences but 
instead are associated with disruption of long-distance regulatory 
elements (42). In this respect, the Tg and knockout technologies 
are complementary in illustrating gene function. In the H-Tx rat, 
2 of the susceptibility loci for hydrocephaly are mapped to chro-
mosome 4q24–42 and 9q36–38 (43), where genes encoding rat 
PAC1 receptor and PACAP are localized, respectively. In patients, 
elevated PACAP signaling may contribute to CNS abnormalities 
(16, 17, 19). We have shown that altered levels of PACAP signaling 
are associated with hydrocephalus in mice. Therefore, misregu-
lation or mutations in genes encoding PACAP and/or the PAC1 
receptor could be associated with hydrocephalus-related neurode-
velopmental disorders in mice, rats, and humans.
Figure 8
Neurogenesis but not oligodendrocyte generation is affected by PAC1 
overexpression. (A and B) Double immunostaining of E15.5 cortex 
with BrdU (red) and GLAST (green) showed reduced BrdU labeling 
in the subventricular zone (SVZ) of developing cortex of Tg embryos 
(B) compared with that in the WT control (A). Note that most, if not all, 
of the BrdU-labeled cells coexpressed GLAST. (C and D) Colabeling 
of E15.5 cortex with BrdU and PDGFRa. Cells in the ventricular zone 
(VZ) and SVZ at this stage were weakly stained with anti-PDGFRa, 
indicating they are multipotential neural stem cells. No significant dif-
ference in PDGFRa staining was observed at E15.5 in cortex of WT 
and Tg embryos. (E and F) Immunostaining of Sox10 showed compa-
rable labeling of Sox10-positive cells in P12 striatum of WT (E) and Tg 
(F) littermates. Scale bars: 50 mm in A–F.
Figure 9
PACAP promotes neurite outgrowth and migration in neurons 
of Tg embryos. At E15.5, neurons from developing cortex of Tg 
or WT embryos were cultured on 35-mm dishes at a density of 
104 cells/ml in the absence (A and C) or presence (B and D) of 
PACAP (10–7 M) for 4 hours prior to recording. Migrational behav-
ior was recorded with time-lapse imaging for the subsequent 8 
hours, and migration rates of 100–120 cells under each condi-
tion from 3 independent experiments were quantified by 1-way 
ANOVA (*P < 0.05) (E). Note that (a) PACAP promotes neurite 
outgrowth in neurons of both WT and Tg embryos (B and D) and 
(b) PACAP significantly increases the migration rate of neurons 
of Tg embryos (E).
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Methods
PAC clones. PAC clones were obtained by hybridization of the RPCI-1 
Human PAC Library (21) and analyzed by FISH, restriction map-
ping, pulsed-field electrophoresis, Southern blotting, STS mapping, 
PCR, sequencing, and bioinformatics (Basic Local Alignment Search 
Tool [BLAST], http://www.ncbi.nlm.nih.gov/BLAST/; UCSC Human 
Genome Browser, http://genome.ucsc.edu/cgi-bin/hgGateway; and 
GeneJockey II, Biosoft).
Targeted modification. We have adopted the bacterial artificial chromo-
some modification protocol (20) for introducing an IRES-lacZ reporter 
gene into 204D22, with a 791-bp HindIII fragment and the adjacent 
1.6-kb HindIII-SacI fragment flanking the PAC1 stop codon as homolo-
gous recombination arms. A 4-kb IRES-lacZ-polyA cassette was inserted 
between the 2 arms. The 7.4-kb homologous recombination cassette was 
reexcised with BamHI-SalI and cloned into the pSV1 vector. The final con-
struct was transformed into 204D22, and correct homologous recombi-
nants were identified by Southern hybridization.
Generation of Tg mice. All experimental procedures were conducted in 
accordance with the United Kingdom Animals (Scientific Procedures) Act 
of 1986 and were approved by the Ethical Review Committee, University 
of Aberdeen, and the Home Office (London, United Kingdom). Tg found-
ers were produced as described before (12) with NotI-digested PAC DNA 
and characterized using 6 pairs of transgene-specific PCR primers. The 
transgene copy number was determined by semiquantitative PCR of Het 
genomic DNA, with primers PAC1For (5′-CAGGATTATTACTACCTGTC-
3′) and PAC1Rev (5′-GGAAGAAGGTCTCCACCAGC-3′) at 14–24 cycles 
with Expand Long Template System (Roche Diagnostics) using NIH Image 
software (version 1.61; http://rsb.info.nih.gov/nih-image/).
Expression of the transgene. After genotyping with yolk sac DNA, RNA was 
extracted from individual E10.5 embryos using RNAzol B (Biogenesis). RT 
was carried out with 1 mg total RNA using Omniscript kits (QIAGEN) at 37°C 
for 1 hour. RT-PCR was performed with primers PAC1For and PAC1Rev for 
30 cycles. PCR products were digested with RsaI and resolved on agarose gels. 
X-gal staining of embryos was done as described previously (12).
Tissue preparation and histological analysis. Adult mice were humanely killed 
with a lethal dose of sodium pentobarbitone and perfused transcardially 
with cold paraformaldehyde (4%). Newborn mice were killed with sodium 
pentobarbitone and immersed in the fixative for 4 hours. E12.5 and E15.5 
embryos were dissected and fixed for 2 hours. After cryoprotection with 15% 
sucrose in PBS overnight, serial coronal brain sections or transverse embryo 
sections at 12 mm were processed in a cryostat (CM1850; Leica Microsys-
tems) and mounted on Polysine slides (VWR). Sections were stained with 
cresyl violet, H&E, neutral red, oil red O, X-gal, or Abs (see below).
BrdU labeling and TUNEL assay. Time-mated pregnant females were killed 
50 minutes after BrdU injection (i.p., 50 mg/kg body weight). Embryos were 
fixed and sectioned as described above. For BrdU immunostaining, sections 
were treated with 0.4% pepsin (Sigma-Aldrich) in PBS for 30 minutes at 
37°C, denatured with 2 N HCl for 30 minutes at 37°C, and neutralized with 
0.1 M sodium borate (pH 8.5) for 10 minutes at room temperature. BrdU 
incorporation assays (BD Biosciences) and TUNEL assays (Roche Diagnos-
tics) were executed according to the manufacturers’ instructions.
Immunohistochemistry. Sections were immunohistochemically processed as 
described previously (44). The primary Abs were mouse anti-BrdU (1:200; 
BD Biosciences) and rabbit anti-GFAP (1:1,000; Dako). The secondary Abs 
included biotinylated goat anti-mouse or anti-rabbit secondary Ab (1:400; 
Sigma-Aldrich). Immunofluorescence staining was carried out with primary 
Figure 10
Disorganized cilia in ventricular ependyma but not in choroid plexus 
of Tg mice. Brains from three 5-week-old Tg2 mice (C–E, G, and 
I) and 2 WT (A, B, F, and H) littermates were coronally sectioned. 
Sections were costained with Hoechst (blue), anti–acetylated 
a-tubulin (red), and anti-Polaris (green) (A–E, H, and I) or stained 
with anti–phospho-CREB (F and G). Insets in B, D, H, and I are 
magnified views of cilia (arrowheads) in the respective panels. 
Note that ependyma of Tg mice exhibited disorganized cilia and 
increased phospho-CREB reactivity. Scale bars: 50 mm in A–I and 
5 mm in insets of B, D, H, and I.
Figure 11
Elevated PKA and PKC activity in PAC1-overexpressing mice. Pro-
teins were extracted from brains of WT (lane 1), Tg3 (lane 2), Tg2 (lane 
3), and Tg1 (lane 4) mice. (A) One hundred micrograms of total pro-
teins were resolved by SDS-PAGE and sequentially probed with Abs 
against phospho-CREB (p-CREB), total CREB, and tubulin. (B) Thirty-
five micrograms of proteins were run on SDS-PAGE and sequentially 
immunoblotted with Abs against phospho-MARCKS (p-MARCKS), 
total MARCKS, and tubulin. The relative abundance of proteins CREB 
and phospho-CREB (C) or MARCKS and phospho-MARCKS (D) was 
quantified from 4 independent immunoblots.
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Abs guinea pig anti-GLAST (1:4,000; Chemicon International), guinea pig 
anti-Sox10 (1:2,000; kindly provided by Michael Wegner, University Medi-
cal Center Hamburg-Eppendorf, Hamburg, Germany), rabbit anti-PDG-
FRa (1:100, Abcam), rabbit anti-Polaris (1:500; a gift from Bradley K. Yoder, 
University of Alabama at Birmingham, Birmingham, Alabama, USA), rabbit 
anti–phospho-CREB (1:200; Upstate USA Inc.), and mouse anti–acetylated 
a-tubulin (1:1,500; Sigma-Aldrich). The secondary Abs were FITC-conju-
gated donkey anti-guinea pig IgG (1:200; Jackson ImmunoResearch Labo-
ratories Inc.), FITC-conjugated donkey anti-rabbit IgG (1:400; Invitrogen), 
and Texas red–conjugated donkey anti-mouse IgG (1:1,000; Invitrogen).
Immunoblotting. Soluble proteins from whole-brain homogenates (35 mg 
for MARCKS or 100 mg for CREB) were resolved by SDS–PAGE and trans-
ferred to nitrocellulose membranes (Bio-Rad). The membranes were 
immunoblotted with primary Abs goat anti-MARCKS (1:5,000; Santa Cruz 
Biotechnology Inc.), rabbit anti–phospho-MARCKS (Ser152/156) (1:250; 
Cell Signaling Technology), rabbit anti-CREB (1:750; Cell Signaling Tech-
nology), rabbit anti–phospho-CREB (1:200; Upstate USA Inc.), and mouse 
anti–acetylated a-tubulin (1:500,000; Sigma-Aldrich), followed by secondary 
Abs donkey anti-goat IgG HRP-linked Ab (1:3,000; Santa Cruz Biotechnol-
ogy Inc.), goat anti-rabbit IgG HRP-linked Ab (1:3,000; New England Biolabs 
Inc.), and goat anti-mouse IgG (Fc specific)–peroxidase Ab (1:20,000; Sigma-
Aldrich). The immunoreactive bands were visualized using ECL (Sigma-
Aldrich) and quantified with an imaging densitometer (Bio-Rad GS-690).
Migration assay. E15.5 primary neurons were prepared as described previ-
ously (44) at a density of 104 cells/ml in neurobasal medium (Invitrogen) 
supplemented with 2% B27 (Invitrogen) and 2 mM glutamine (Sigma-
Aldrich). Three milliliters of cells were plated per 35-mm dish precoated 
with poly-d-lysine and cultured at 37°C with 5% CO2. Cytosine arabinoside 
(10 mM) was added 24 hours after plating to prevent proliferation of non-
neuronal cells. PACAP1–38 (10–7 M) was added 4 hours before and during 
time-lapse recording, and the recording was carried out in CO2-indepen-
dent medium (Invitrogen) supplemented with 2 mM glutamine and 15% 
FCS. Neuronal migration was time-lapse recorded on MetaMorph (Uni-
versal Imaging Corp.) and a Digital Pixel imaging system (Digital Pixel) 
in a temperature-controlled chamber. Data analysis was processed with 
MetaMorph software.
Statistics. Images were captured by an Axiovert 40CFL microscope and 
quantified with AxioVision Rel. 4.5 software (Zeiss). Data were analyzed by 
1-way ANOVA and are presented as mean ± SD. P < 0.05 was considered to 
be statistically significant.
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